Key statistics
On Tuesday, BIOAGE Labs Inc (Y7G:MUN) closed at 17.40, -13.00% below its 52-week high of 20.00, set on Jan 15, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.20 |
|---|---|
| High | 17.40 |
| Low | 17.20 |
| Bid | -- |
| Offer | -- |
| Previous close | 17.80 |
| Average volume | 2.06k |
|---|---|
| Shares outstanding | 41.75m |
| Free float | 40.68m |
| P/E (TTM) | -- |
| Market cap | 856.24m USD |
| EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 08:23 GMT.
More ▼
Press releases
- Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025
- Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025
- Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)
- BLA for subcutaneous formulation of Leqembi® accepted in China
- Leqembi included in China's commercial insurance innovative drug list
- Leqembi included in China's commercial insurance innovative drug list
- New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
- New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
- New data on lecanemab to be presented at CTAD conference
- New data on lecanemab to be presented at CTAD conference
More ▼
